Oncotype DX

This is the gene test being conducted on my cancer tissue (not on the lobes as previously posted). It was developed for women with early-stage invasive breast cancer who are ER+ (estrogen receptor- positive) and whose lymph nodes do not contain cancer. The test will determine the likelihood of disease recurrence within 10 years of initial diagnosis. My oncologist has said this test will show us if I really need chemotherapy. I will definitely have hormone therapy regardless the outcome of this special test. Hope to hear sometime next week about the results.